Alnylam Pharmaceuticals
ALNY
#570
Rank
S$54.72 B
Marketcap
S$410.14
Share price
0.26%
Change (1 day)
30.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company